Role of CX3CL1/fractalkine in osteoclast differentiation and bone resorption

Journal of Immunology

Volumn 183, Issue 12, 2009, Pages 7825-7831

  Koizumi, Keiichi ^a   Saitoh, Yurika ^a   Minami, Takayuki ^a   Takeno, Nobuhiro ^a   Tsuneyama, Koichi ^a   Miyahara, Tatsuro ^a   Nakayama, Takashi ^b   Sakurai, Hiroaki ^a   Takano, Yasuo ^a   Nishimura, Miyuki ^c   Imai, Toshio ^c   Yoshie, Osamu ^b   Saiki, Ikuo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KAN Research Institute Inc ^*  (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; RECEPTOR ANTIBODY; CHEMOKINE RECEPTOR; CX3CL1 PROTEIN, MOUSE; CX3CR1 PROTEIN, HUMAN; CX3CR1 PROTEIN, MOUSE;

ARTICLE; BONE MARROW CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; CELL COMMUNICATION; CELL CULTURE; CELL LINE; CELL MOTION; COCULTURE; COMPARATIVE STUDY; CYTOLOGY; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; NEWBORN; OSTEOBLAST; PHYSIOLOGY; STEM CELL;

ANIMALS; ANIMALS, NEWBORN; BONE MARROW CELLS; BONE RESORPTION; CELL ADHESION; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL LINE; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CX3CL1; COCULTURE TECHNIQUES; FEMALE; HUMANS; MICE; OSTEOBLASTS; OSTEOCLASTS; RECEPTORS, CHEMOKINE; STEM CELLS;

EID: 76249099065     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803627     Document Type: Article

References (34)

1. Datta, H. K., W. F. Ng, J. A. Walker, S. P. Tuck, and S. S. Varanasi. 2008. The cell biology of bone metabolism. J. Clin. Pathol. 61: 577-587.
2. Matsuo, K., and N. Irie. 2008. Osteoclast-osteoblast communication. Arch. Biochem. Biophys. 473: 201-209.
3. Yoshie, O., T. Imai, and H. Nomiyama. 2001. Chemokines in immunity. Adv. Immunol. 78: 57-110.
4. Li, X., L. Qin, M. Bergenstock, L. M. Bevelock, D. V. Novack, and N. C. Partridge. 2007. Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre/osteoclasts. J. Biol. Chem. 282: 33098-33106. (Pubitemid 350159306)
5. Kim, M. S., C. J. Day, and N. A. Morrison. 2005. MCP-1 is induced by receptor activator of nuclear factor-κB ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation. J. Biol. Chem. 280: 16163-16169.
6. Kim, M. S., C. L. Magno, C. J. Day, and N. A. Morrison. 2006. Induction of chemokines and chemokine receptors CCR2b and CCR4 in authentic human osteoclasts differentiated with RANKL and osteoclast like cells differentiated by MCP-1 and RANTES. J. Cell Biochem. 97: 512-518.
7. Choi, S. J., J. C. Cruz, F. Craig, H. Chung, R. D. Devlin, G. D. Roodman, and M. Alsina. 2000. Macrophage inflammatory protein 1-α is a potential osteoclast stimulatory factor in multiple myeloma. Blood 96: 671-675.
8. Garton, K. J., P. J. Gough, C. P. Blobel, G. Murphy, D. R. Greaves, P. J. Dempsey, and E. W. Raines. 2001. Tumor necrosis factor-α-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J. Biol. Chem. 276: 37993-38001. (Pubitemid 37384050)
9. Hundhausen, C., D. Misztela, T. A. Berkhout, N. Broadway, P. Saftig, K. Reiss, D. Hartmann, F. Fahrenholz, R. Postina, V. Matthews, K. J. Kallen, S. Rose-John, and A. Ludwig. 2003. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 102: 1186-1195.
10. Imai, T., K. Hieshima, C. Haskell, M. Baba, M. Nagira, M. Nishimura, M. Kakizaki, S. Takagi, H. Nomiyama, T. J. Schall, and O. Yoshie. 1997. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91: 521-530.
11. Fong, A. M., L. A. Robinson, D. A. Steeber, T. F. Tedder, O. Yoshie, T. Imai, and D. D. Patel. 1998. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J. Exp. Med. 188: 1413-1419.
12. Nakamura, E. S., K. Koizumi, M. Kobayashi, Y. Saitoh, Y. Arita, T. Nakayama, H. Sakurai, O. Yoshie, and I. Saiki. 2006. RANKL-induced CCL22/macrophage-derived chemokine produced from osteoclasts potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4. Clin. Exp. Metastasis 23: 9-18.
13. Miyahara, T., T. Katoh, M. Watanabe, Y. Mikami, S. Uchida, M. Hosoe, T. Sakuma, N. Nemoto, K. Takayama, and T. Komurasaki. 2004. Involvement of into-activated protein kinases and protein kinase C in cadmium-induced prostaglandin E2 production in primary mouse osteoblastic cells. Toxicology 200: 159-167.
14. Hojo, S., K. Koizumi, K. Tsuneyama, Y. Arita, Z. Cui, K. Shinohara, T. Minami, I. Hashimoto, T. Nakayama, H. Sakurai, et al. 2007. High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer. Cancer Res. 67: 4725-4731.
15. Nanki, T., Y. Urasaki, T. Imai, M. Nishimura, K. Muramoto, T. Kubota, and N. Miyasaka. 2004. Inhibition of fractalkine ameliorates murine collagen-induced arthritis. J. Immunol. 173: 7010-7016. (Pubitemid 39541090)
16. Kanegasaki, S., Y. Nomura, N. Nitta, S. Akiyama, T. Tamatani, Y. Goshoh, T. Yoshida, T. Sato, and Y. Kikuchi. 2003. A novel optical assay system for the quantitative measurement of chemotaxis. J. Immunol. Methods 282: 1-11. (Pubitemid 37357028)
17. Saitoh, Y., K. Koizumi, T. Minami, K. Sekine, H. Sakurai, and I. Saiki. 2006. A derivative of aminopeptidase inhibitor (BE15) has a dual inhibitory effect of invasion and motility on tumor and endothelial cells. Biol. Pharm. Bull. 29: 709-712.
18. Kurachi, T., I. Morita, and S. Murota. 1993. Involvement of adhesion molecules LFA-1 and ICAM-1 in osteoclast development. Biochim. Biophys. Acta 1178: 259-266.
19. Parfitt, A. M., M. K. Drezner, F. H. Glorieux, J. A. Kanis, H. Malluche, P. J. Meunier, S. M. Ott, and R. R. Recker. 1987. Bone histomorphometry: standardization of nomenclature, symbols, and units: Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2: 595-610.
20. Granholm, S., P. Lundberg, and U. H. Lerner. 2007. Calcitonin inhibits osteoclast formation in mouse haematopoetic cells independently of transcriptional regulation by receptor activator of NF-κB and c-Fms. J. Endocrinol. 195: 415-427.
21. Yu, X., Y. Huang, P. Collin-Osdoby, and P. Osdoby. 2004. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts. J. Bone Miner. Res. 19: 2065-2077. (Pubitemid 41103422)
22. Li, X., N. Udagawa, M. Takami, N. Sato, Y. Kobayashi, and N. Takahashi. 2003. p38 Mitogen-activated protein kinase is crucially involved in osteoclast differentiation but not in cytokine production, phagocytosis, or dendritic cell differentiation of bone marrow macrophages. Endocrinology 144: 4999-5005.
23. Bazan, J. F., K. B. Bacon, G. Hardiman, W. Wang, K. Soo, D. Rossi, D. R. Greaves, A. Zlotnik, and T. J. Schall. 1997. A new class of membrane-bound chemokine with a CX3C motif. Nature 385: 640-644.
24. Kanazawa, N., T. Nakamura, K. Tashiro, M. Muramatsu, K. Morita, K. Yoneda, K. Inaba, S. Imamura, and T. Honjo. 1999. Fractalkine and macrophage-derived chemokine: T cell-attracting chemokines expressed in T cell area dendritic cells. Eur. J. Immunol. 29: 1925-1932. (Pubitemid 29265548)
25. Muehlhoefer, A., L. J. Saubermann, X. Gu, K. Luedtke-Heckenkamp, R. Xavier, R. S. Blumberg, D. K. Podolsky, R. P. MacDermott, and H. C. Reinecker. 2000. Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa. J. Immunol. 164: 3368-3376. (Pubitemid 30149003)
26. Han, J. H., S. J. Choi, N. Kurihara, M. Koide, Y. Oba, and G. D. Roodman. 2001. Macrophage inflammatory protein-1α is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor κB ligand. Blood 97: 3349-3353.
27. Yang, M., G. Mailhot, C. A. MacKay, A. Mason-Savas, J. Aubin, and P. R. Odgren. 2006. Chemokine and chemokine receptor expression during colony stimulating factor-1-induced osteoclast differentiation in the toothless osteopetrotic rat: a key role for CCL9 (MIP-1γ) in osteoclastogenesis in vivo and in vitro. Blood 107: 2262-2270.
28. Boehme, S. A., F. M. Lio, D. Maciejewski-Lenoir, K. B. Bacon, and P. J. Conlon. 2000. The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia. J. Immunol. 165: 397-403.
29. Smolen, J. S., D. Aletaha, and E. Keystone. 2005. Superior efficacy of combination therapy for rheumatoid arthritis: fact or fiction? Arthritis Rheum. 52: 2975-2983.
30. McClung, M. R. 2006. Inhibition of RANKL as a treatment for osteoporosis: preclinical and early clinical studies. Curr. Osteoporos. Rep. 4: 28-33.
31. Yoneda, T., and T. Hiraga. 2005. Crosstalk between cancer cells and bone microenvironment in bone metastasis. Biochem. Biophys. Res. Commun. 328: 679-687. (Pubitemid 40208305)
32. Sweeney, S. E., and G. S. Firestein. 2004. Rheumatoid arthritis: regulation of synovial inflammation. Int. J. Biochem. Cell Biol. 36: 372-378. (Pubitemid 37542434)
33. Goldring, S. R. 2003. Pathogenesis of bone and cartilage destruction in rheumatoid arthritis. Rheumatology (Oxford) 42(Suppl 2): ii11-ii16.
34. Koizumi, K., S. Hojo, T. Akashi, K. Yasumoto, and I. Saiki. 2007. Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Sci. 98: 1652-1658. (Pubitemid 47487897)